209 related articles for article (PubMed ID: 33802213)
1. Analysis of Brain Functions in Men with Prostate Cancer under Androgen Deprivation Therapy: A One-Year Longitudinal Study.
Sánchez-Martínez V; Buigues C; Navarro-Martínez R; García-Villodre L; Jeghalef N; Serrano-Carrascosa M; Rubio-Briones J; Cauli O
Life (Basel); 2021 Mar; 11(3):. PubMed ID: 33802213
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study.
García-Sánchez J; Mafla-España MA; Torregrosa MD; Cauli O
Breast; 2022 Dec; 66():310-316. PubMed ID: 36462308
[TBL] [Abstract][Full Text] [Related]
3. Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy.
Mafla-España MA; Torregrosa MD; Beamud-Cortés M; Bermell-Marco L; Rubio-Briones J; Cauli O
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002324
[TBL] [Abstract][Full Text] [Related]
4. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
[TBL] [Abstract][Full Text] [Related]
5. A 2-year prospective analysis of insomnia as a mediator of the relationship between androgen deprivation therapy and perceived cognitive function in men with prostate cancer.
Garland SN; Savard J; Eisel SL; Wassersug RJ; Rockwood NJ; Thoms J; Jim HSL; Gonzalez BD
Cancer; 2021 Dec; 127(24):4656-4664. PubMed ID: 34411294
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Frailty Criteria, Cognitive Function, Depressive and Insomnia Symptoms in Men with Localized and Advanced Prostate Cancer under Androgen Deprivation Therapy.
Mafla-España MA; Torregrosa MD; Beamud-Cortés M; Bermell-Marco L; Rubio-Briones J; Cauli O
Healthcare (Basel); 2023 Apr; 11(9):. PubMed ID: 37174808
[TBL] [Abstract][Full Text] [Related]
7. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
[TBL] [Abstract][Full Text] [Related]
8. Study of testosterone-guided androgen deprivation therapy in management of prostate cancer.
Niraula S; Templeton AJ; Vera-Badillo FE; Joshua AM; Sridhar SS; Cheung PW; Yip PM; Dodd A; Nugent Z; Tannock IF
Prostate; 2016 Feb; 76(2):235-42. PubMed ID: 26768279
[TBL] [Abstract][Full Text] [Related]
9. Combined androgen blockade (CAB) versus luteinizing hormone-releasing hormone (LHRH) agonist monotherapy for androgen deprivation therapy.
Park HS; Shin HB; Woo SH; Jeon SH; Lee SH; Kang SH; Shim JS; Shin DW; Park J
World J Urol; 2020 Apr; 38(4):971-979. PubMed ID: 31187203
[TBL] [Abstract][Full Text] [Related]
10. Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer.
Delgado J; Ory J; Loloi J; Deebel NA; Bernstein A; Nackeeran S; Zucker I; Ramasamy R
Cureus; 2022 Dec; 14(12):e32699. PubMed ID: 36686106
[TBL] [Abstract][Full Text] [Related]
11. Androgen deprivation therapy and radiation for prostate cancer-cognitive impairment, sleep, symptom burden: a prospective study.
Tulk J; Rash JA; Thoms J; Wassersug R; Gonzalez B; Garland SN
BMJ Support Palliat Care; 2023 Dec; 13(e2):e454-e463. PubMed ID: 34330793
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
13. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
[TBL] [Abstract][Full Text] [Related]
14. Quality of sleep in patients receiving androgen deprivation therapy for prostate cancer.
Koskderelioglu A; Gedizlioglu M; Ceylan Y; Gunlusoy B; Kahyaoglu N
Neurol Sci; 2017 Aug; 38(8):1445-1451. PubMed ID: 28484881
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
Hara N; Takizawa I; Isahaya E; Nishiyama T; Hoshii T; Ishizaki F; Takahashi K
Urol Oncol; 2012 Sep; 30(5):596-601. PubMed ID: 21458314
[TBL] [Abstract][Full Text] [Related]
16. Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?
Shim M; Bang WJ; Oh CY; Lee YS; Cho JS
Prostate Int; 2022 Mar; 10(1):68-74. PubMed ID: 35510099
[TBL] [Abstract][Full Text] [Related]
17. Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model.
Hong JH; Huang CY; Chang CH; Muo CH; Jaw FS; Lu YC; Chung CJ
Cancer Epidemiol; 2020 Feb; 64():101657. PubMed ID: 31918180
[TBL] [Abstract][Full Text] [Related]
18. The Association of A Number of Risk Factors With Depression in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy.
Kim CH; Kim KT; Oh JK; Chung KJ; Kim TB; Jung H; Yoon SJ; Kim KH
Urol J; 2018 May; 15(3):104-108. PubMed ID: 29388185
[TBL] [Abstract][Full Text] [Related]
19. Cognitive function in patients on androgen suppression: A prospective, multicentric study.
Morote J; Tabernero ÁJ; Álvarez-Ossorio JL; Ciria JP; Domínguez-Escrig JL; Vázquez F; Angulo J; López FJ; de La Iglesia R; Romero J;
Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):114-120. PubMed ID: 29102054
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved.
Wibowo E
Curr Neuropharmacol; 2017; 15(7):1043-1055. PubMed ID: 28294068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
